20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – TEL CENTRAL +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 – WWW.WHO.INT
Ref.: C.L.23.2020
The Director-General of the World Health Organization (WHO) presents his compliments
to Member States and Associate Members and has the honour to refer to the Written Silence
Procedure adopted by the Seventy-third World Health Assembly on 18 May 2020 through
decision WHA73(7).
The Written Silence Procedure operates following the suspension of the Seventy-third
World Health Assembly session and pending its resumption and applies in respect of any
proposal that the President of the Health Assembly determines, following informal consultations
or because the proposal was recommended by the Executive Board for adoption, is suitable for
adoption without further discussion by the Health Assembly.
Following the informal consultations with Member States on 3 and 26 June 2020, and
based on the feedback received from Member States, the President Ms Keva Bain, Ambassador,
Permanent Representative of the Commonwealth of the Bahamas to the United Nations Office in
Geneva, made the determination that the following proposals are suitable for adoption without
further discussion by the Health Assembly and should therefore be subject to the written silence
procedure:
Proposal submitted by Member States:
1. Strengthening global immunization efforts to leave no one behind submitted by the
United States of America 1
Proposals recommended by the Executive Board for adoption:
2. Resolution EB146.R6 Cervical cancer prevention and control: accelerating the
elimination of cervical cancer as a public health problem
3. Resolution EB146.R7 Global strategy for tuberculosis research and innovation
4. Resolution EB146.R8 Integrated people-centred eye care, including preventable
vision impairment and blindness
5. Resolution EB146.R9 Strengthening efforts on food safety
6. Resolution EB146.R10 Strengthening preparedness for health emergencies:
implementation of the International Health Regulations (2005)
7. Decision EB146(3) Geneva buildings renovation strategy
1
https://www.who.int/immunization/IA2030_draft_4_WHA.pdf?ua=1.
Page 2
C.L.23.2020
8. Decision EB146(10) Global strategy and plan of action on public health, innovation
and intellectual property
9. Decision EB146(13) Decade of Healthy Ageing
10. Decision EB146(16) Travel and other entitlements of the Chair of the Executive
Board and other Board members
11. Decision EB146(19) Influenza preparedness
12. Decision EB146(21) WHO reform: governance
13. Decision EB146(22) Evaluation of the election of the Director-General of the World
Health Organization
Member States are invited to signal in writing to the following email address
[email protected] by 23 July no later than 18:00 CEST any objection to the
adoption of any of the abovementioned proposals. It is understood that objections are severable
in that an objection to one proposal will not affect any other proposal.
In absence of the receipt by 23 July of any written objection from a Member State, the
proposal(s) concerned will be considered as having been validly adopted by the Health
Assembly. The adopted proposal(s) will be referred to the Health Assembly at its resumed
session for information only.
In the event of the receipt by 23 July of one or more written objections from a Member
State, the proposal(s) concerned will be considered as having not been adopted by the Health
Assembly. The proposal(s) concerned will be referred to the Health Assembly for consideration
at its resumed session.
The Director-General will communicate the outcome of the written silence procedure to all
Member States as soon as possible after 23 July. In the case of a proposal that is adopted
pursuant to the written silence procedure, the date of the Director-General’s communication to
that effect will be the date of adoption of the proposal.
Without prejudice to the above, any Member State may explain its position in respect of a
proposal that is subject to the written silence procedure by submitting a written statement
relating thereto, for posting on the WHO website. Written statements should be received by the
Director-General by 23 July. Written statements will be made available on the WHO website for
information purposes only. They will appear as submitted and in the language(s) of submission.
Submission of a written statement in accordance with this paragraph will not be considered as an
objection to the adoption of a proposal.
The Director-General of the World Health Organization takes this opportunity to renew to
Member States and Associate Members the assurance of his highest consideration.
GENEVA, 9 July 2020
Saatja: <
[email protected]>
Saadetud: 10.07.2020 19:19
Teema: WHO: C.L.23.2020 (Written silence procedure)
Dear Member States of the World Health Organization,Please find attached,
in the six official languages, C.L.23.2020 regarding the Written silence
procedure.Best regards,Department of Governing BodiesWorld Health
Organization